| Sydney Grohman, | |
|
9346 Oak Ave, Waconia, MN 55387-9422 | |
| (952) 223-2506 | |
| Not Available |
| Full Name | Sydney Grohman |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 9346 Oak Ave, Waconia, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336854835 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | (* (Not Available)) | Primary |
| Provider Name | Fairview Express Care |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1053952606 PECOS PAC ID: 3375645179 Enrollment ID: O20081028000548 |
News Archive
Oramed Pharmaceticals, Inc., a developer of oral drug delivery systems, announced today that it has received approval from the Institutional Review Board (IRB) to commence human clinical trials of an oral GLP-1 Analog.
In this "End the Neglect" blog post, Alan Fenwick, director of the Schistosomaisis Control Initiative and professor of Tropical Parasitology at Imperial College in London, examines Burundi's progress in combating neglected tropical diseases.
A multidisciplinary team at UT Southwestern Medical Center has found that measuring the oxygenation of tumors can be a valuable tool in guiding radiation therapy, opening the door for personalized therapies that keep tumors in check with oxygen enhancement.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the U.S. Food and Drug Administration has issued a complete response letter regarding the New Drug Application for BYDUREON™ (exenatide for extended-release injectable suspension).
A new study in East Asian women has identified three genetic changes linked to an increased risk of breast cancer. The research, led by Vanderbilt University investigators, was published online July 20 in Nature Genetics.
› Verified 4 days ago
| Provider Name | Healtheast Outpatient Services Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1225382526 PECOS PAC ID: 0941447304 Enrollment ID: O20130503000040 |
News Archive
Oramed Pharmaceticals, Inc., a developer of oral drug delivery systems, announced today that it has received approval from the Institutional Review Board (IRB) to commence human clinical trials of an oral GLP-1 Analog.
In this "End the Neglect" blog post, Alan Fenwick, director of the Schistosomaisis Control Initiative and professor of Tropical Parasitology at Imperial College in London, examines Burundi's progress in combating neglected tropical diseases.
A multidisciplinary team at UT Southwestern Medical Center has found that measuring the oxygenation of tumors can be a valuable tool in guiding radiation therapy, opening the door for personalized therapies that keep tumors in check with oxygen enhancement.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the U.S. Food and Drug Administration has issued a complete response letter regarding the New Drug Application for BYDUREON™ (exenatide for extended-release injectable suspension).
A new study in East Asian women has identified three genetic changes linked to an increased risk of breast cancer. The research, led by Vanderbilt University investigators, was published online July 20 in Nature Genetics.
› Verified 4 days ago
| Provider Name | Sunnydays Therapy Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1891914412 PECOS PAC ID: 5698900314 Enrollment ID: O20131104001388 |
News Archive
Oramed Pharmaceticals, Inc., a developer of oral drug delivery systems, announced today that it has received approval from the Institutional Review Board (IRB) to commence human clinical trials of an oral GLP-1 Analog.
In this "End the Neglect" blog post, Alan Fenwick, director of the Schistosomaisis Control Initiative and professor of Tropical Parasitology at Imperial College in London, examines Burundi's progress in combating neglected tropical diseases.
A multidisciplinary team at UT Southwestern Medical Center has found that measuring the oxygenation of tumors can be a valuable tool in guiding radiation therapy, opening the door for personalized therapies that keep tumors in check with oxygen enhancement.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the U.S. Food and Drug Administration has issued a complete response letter regarding the New Drug Application for BYDUREON™ (exenatide for extended-release injectable suspension).
A new study in East Asian women has identified three genetic changes linked to an increased risk of breast cancer. The research, led by Vanderbilt University investigators, was published online July 20 in Nature Genetics.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sydney Grohman, 9346 Oak Ave, Waconia, MN 55387-9422 Ph: (952) 223-2506 | Sydney Grohman, 9346 Oak Ave, Waconia, MN 55387-9422 Ph: (952) 223-2506 |
News Archive
Oramed Pharmaceticals, Inc., a developer of oral drug delivery systems, announced today that it has received approval from the Institutional Review Board (IRB) to commence human clinical trials of an oral GLP-1 Analog.
In this "End the Neglect" blog post, Alan Fenwick, director of the Schistosomaisis Control Initiative and professor of Tropical Parasitology at Imperial College in London, examines Burundi's progress in combating neglected tropical diseases.
A multidisciplinary team at UT Southwestern Medical Center has found that measuring the oxygenation of tumors can be a valuable tool in guiding radiation therapy, opening the door for personalized therapies that keep tumors in check with oxygen enhancement.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the U.S. Food and Drug Administration has issued a complete response letter regarding the New Drug Application for BYDUREON™ (exenatide for extended-release injectable suspension).
A new study in East Asian women has identified three genetic changes linked to an increased risk of breast cancer. The research, led by Vanderbilt University investigators, was published online July 20 in Nature Genetics.
› Verified 4 days ago
Nora Carlson, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 9346 Oak Ave, Waconia, MN 55387 Phone: 952-223-2506 | |
Kirstin Amber Peters, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9346 Oak Ave, Waconia, MN 55387 Phone: 952-223-2506 | |
Andrea Elizabeth Guimont, MS, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 9346 Oak Ave, Waconia, MN 55387 Phone: 952-223-2506 | |
Jami Eilers, MA, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9346 Oak Ave, Waconia, MN 55387 Phone: 952-223-2506 | |
Madelin Roberts, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 9346 Oak Ave, Waconia, MN 55387 Phone: 952-223-2506 | |
Cerena Ice, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 9346 Oak Ave, Waconia, MN 55387 Phone: 952-223-2506 | |
Christina Dalki, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 9346 Oak Ave, Waconia, MN 55387 Phone: 952-223-2506 |